David Edelman, Thrivable CEO & Co-Founder, talked with Sean McDonnell of the Cleveland Plain Dealer about Thrivable's origin story and what the company is doing today to fill a big gap in the healthcare space.
Bedford Heights, OH, January 23, 2024 - When the FDA approved it in 2006, many people thought that Exubera — an inhalable, dry powder form of insulin that didn’t need injections — would be a huge hit.
Instead, it ended up being a huge flop and was pulled from shelves soon after it was released. While many things may have contributed to its failure, one thing stands out to David Edelman, a Cleveland-area startup CEO and founder of Diabetes Daily...
Read the article on Cleveland.com >>